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Experimental autoimmune thyroiditis can be induced in mice using mouse 
thyroglobulin (MTg)  1  when it is emulsified in complete Freund's adjuvant (CFA) 
(1). The disease usually involves both antibody production to MTg and infiltra- 
tion of the thyroid by mononuclear cells; its severity is governed by the genetic 
constitution of the  animals  (2). Whereas  mice with the H-2 k,  H-2q,  or H-2  s 
haplotype are  good responders, developing high antibody titers to MTg and 
extensive  cellular  infiltration of the  thyroid,  those  with  the H-2 b  or H-2 d 
haplotype are considered poor responders with lower antibody titers and little 
infiltration of the thyroid. It has been shown previously, using adoptive transfer 
experiments, that the genetic regulation is dependent upon the presence of 
thymus-derived (T)  lymphocytes (3). These  studies in  poor responder mice, 
which have been thymectomized, irradiated, and reconstituted with T or bone 
marrow-derived (B) cells from good or poor responders and subsequently immu- 
nized with MTg in CFA, show that T cells are required for responsiveness to 
MTg. Moreover, only the transfer of T cells from good responder mice leads to 
infiltration of the thyroid, regardless of the source of B cells. On the other hand, 
using the antigen-binding assay,  it has been demonstrated that normal mice 
have syngeneic MTg-binding B,  but not T,  cells  (4). Also the incidence and 
severity ofthyroiditis are decreased when B cells have been treated with labeled 
MTg by the antigen suicide technique. That only B cells have receptors for MTg 
lends support to the hypothesis that self-tolerance to MTg exists at the T-cell 
level (4, 5). 
Bacterial lipopolysaccharide (LPS) is a mitogen for B cells (6). According to 
some reports, its use seems to obviate the requirement for T cells in the response 
to erythrocytes and hapten conjugates (6, 7). It has been shown to interfere with 
the induction of acquired tolerance to T-cell-dependent antigen in a  manner 
suggesting an effect on B cells (8, 9). However, LPS is also a potent adjuvant for 
T-cell-dependent antigens (10) and there is accumulating evidence for an action 
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on T  cells,  as well as B  cells,  in several systems (11-14).  Therefore,  we have 
studied the effect of LPS on the maintenance of self-tolerance to MTg, since the 
T-cell-dependent responses to MTg are genetically controlled.  We have found 
that LPS can abrogate the natural tolerance to MTg. This effect seems to require 
the  presence of T  cells and  is more pronounced  in good responder  than  poor 
responder mice. 
Materials  and Methods 
Mice.  Congenic strains,  B10.BR (H-2  k) and B10.D2 (H-2d), were obtained from The Jackson 
Laboratory,  Bar Harbor,  Maine.  Congenitally athymic mice on a  BALB/c (H-2  d) background, 
originally obtained from Dr. D. C. Shreffler, Washington University, St. Louis, Mo., were used at 
the ninth generation backcross. All mice were 8- to 10-wk-old females. 
Antigen.  Frozen mouse thyroids  (Pel-Freez Biologicals, Inc.,  Rogers,  Ark.) were processed 
essentially as detailed earlier (15). Briefly, the thyroids were homogenized in phosphate-buffered 
physiologic saline (PBS), pH 7.2, at 4°C with an Omni-Mixer (VirTis Co., Inc., Gardiner, N. Y.) at 
22,000 rpm for 3 min and then extracted overnight at 4°C. An alternate method of homogenization 
with a Teflon-pestle tissue grinder without overnight extraction was also employed. The extract 
was clarified by centrifugation  (15)  and  the MTg precipitated  with 45%  saturated  ammonium 
sulfate as described earlier (16). The MTg was dissolved in 2-3 ml of PBS and dialyzed overnight. 
This solution was further fractionated on a Sephadex G-200 column (2.5 x 90 cm) which had been 
equilibrated  with  0.1  M  phosphate  buffer,  pH  7.2.  The  concentration  of purified  MTg  was 
determined spectrophotometrically at 280 nm or by the biuret reaction (16).  It was sterilized by 
filtration  (Millipore membrane,  0.45  ~m pore size), stored at 4°C,  and used within 3  wk.  For 
immunization, 250/zg of MTg was given with or without adjuvant on days 0 and 7. 
Adjuvants.  CFA was prepared as described previously (1), using 7 mg/ml of killed and dried 
Mycobacterium  tuberculosis,  strains C, DT, and PN (Lederle Laboratories, Pearl River, N. J.). The 
mycobacteria were dispersed in hexadecane (Eastman Kodak Co., Rochester, N. Y.) by sonication 
(Sonifier Cell Disruptor, Model Wl40D; Ultrasonic Industries Inc., Hicksville, N. Y.) for 30 rain 
(17) and emulsified with MTg after the addition of Myverol (Myverol 18-98 distilled monoglycer- 
ides; Distillation Products,  Division of Eastman Kodak, Rochester, N. Y.). 
LPS from Salmonella enteritidis, prepared by Dr. C. D. Jeffries of our department according to 
the method of Ribi (18), had been tested previously for adjuvanticity (19) and mitogenicity (20). It 
was sterilized by filtration and,  except where  noted,  a  dose of 20  ~g was given intravenously 
(i.v.) 3 h  after the injection of MTg on days 0 and 7. 
Cell Transfer Procedure.  T-cell-deficient BI0.BR mice were obtained by thymectomy (21) at 5- 
7 wk of age followed 3-5 wk later by whole body irradiation from a  Cobalt-60 source (22).  The 
animals were maintained  on chlorinated water before and  after irradiation.  After irradiation, 
they were given 2 ×  107 syngeneic bone marrow cells and 2 ×  10  ~ syngeneic thymus cells i.v., each 
in a  0.2 ml vol. Before injection, the bone marrow cells were treated with anti-8 serum (kindly 
supplied by Dr. P. Campbell, National Jewish Hospital, Denver, Col.) plus agarose-adsorbed (23) 
guinea pig complement  (Grand  Island  Biological Co.,  Grand Island,  N.  Y.)  and  washed three 
times. 
Antibody Determination.  Mice were bled from the tail artery at intervals of 7-14 days or at the 
termination of the experiment. Antibodies were titrated in microtiter plates using human group O 
erythrocytes coated with MTg by means of chromium chloride  (24). In some experiments their 
sensitivity to 0.1  M 2-mercaptoethanol  (Eastman  Kodak Co.) was also determined.  Antibody to 
LPS was determined by passive hemagglutination (25) using LPS-coatod human group O erythro- 
cytes in microtiter plates. 
Histology.  At intervals of 7-14 days or at the termination of the experiment, groups of mice 
were killed under ether anesthesia and their thyroids, livers, and kidneys removed for histologic 
examination. The infiltration of mononuclear cells in the thyroid was graded on a scale from 0 to 4 
and expressed as pathology index (1). 
Statistical Analysis.  The standard error of the mean was used for calculation. The statistical 
significance of the differences between control and experimental groups was determined by the 
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Results 
Effect of  LPS on the Immune Response to MTg in Good Responder Mice.  In 
good responder mice, the injection of soluble MTg induces no detectable anti- 
body production or  cellular infiltration in  the thyroid, while MTg given in 
specially prepared CFA results in high antibody titers and severe thyroiditis (2). 
Using MTg alone or in CFA as controls, the capacity of LPS to abrogate self- 
tolerance to MTg was examined. Good responder B10.BR mice were immunized 
with soluble MTg followed by LPS 3 h later on days 0 and 7, a schedule known to 
induce autoimmune thyroiditis in mice treated with MTg in CFA. The animals 
were monitored weekly for antibody level and killed biweekly in groups of three 
to seven for histologic examination of the thyroid. Their livers and kidneys were 
also obtained for sectioning. 
As seen in Fig.  1,  the administration of MTg followed by LPS resulted in 
average log2 hemagglutinin titers approaching 14, which were as high as those 
observed in mice given MTg in CFA. The kinetics of antibody production were 
the same in both groups and all the antibodies were found to be mercaptoethanol 
resistant. Histologically, moderate to severe thyroiditis was observed after day 
21 in mice that had received LPS as adjuvant. In other experiments, mice given 
LPS as adjuvant had no lesions before day 21. The pathology indices in mice that 
had received LPS as adjuvant were highest on day 49, as were those in mice 
given CFA as the adjuvant. In contrast, the injection of MTg alone did not 
induce the  formation of detectable antibody and cellular infiltration of the 
thyroid; no significant difference was  observed between this  group and un- 
treated,  normal mice.  In another experiment, control groups  included mice 
given CFA or LPS without MTg. Neither antibody to MTg nor cellular infiltra- 
tion of the thyroids was detectable in either group. In some animals receiving 
LPS as adjuvant, the antibody to LPS was also determined at intervals from 
days 10 to 28. The average log2 titers ranged from 1.8 to 5.6 and the antibody was 
mercaptoethanol sensitive. 
Careful  examination of the  histologic sections did  not  reveal  discernible 
differences in the type of cells infiltrating the thyroid of good responder mice 
treated with  MTg and LPS or MTg in  CFA.  An example of severe thyroid 
pathology on day 49 from each group is presented in Fig.  2; a  destruction of 
>70% of the thyroid tissue is represented in both sections. At higher magnifica- 
tion  (Fig.  3),  the  mononuclear cell  infiltration  is  clearly shown  with  both 
adjuvants. No lesions were observed in the liver and kidney sections of these 
animals. 
Effect  of  LPS  on  the  Immune  Response  to  MTg  in  Poor  Responder 
Mice.  Genetic regulation of the immune response to MTg is known to occur in 
mice when CFA is used as adjuvant (2). To determine if such regulation also 
played a role in mice given LPS as adjuvant, a poor responder strain congenic to 
B10.BR was tested. The immunization protocol of B10.D2 mice was identical to 
the one used with the  good  responder strain.  The animals were monitored 
weekly for changes in antibody level and sacrificed in groups of three to six for 
histologic examination. The results depicted in Fig.  4  show that LPS as an 
adjuvant was less effective  than CFA in inducing high antibody levels to MTg in 
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FIG.  1.  Effect of LPS on the antibody responses to MTg and thyroid pathology in good 
responder (B10.BR) mice. LPS was given in a dose of 20 ~g i.v. at 3 h ai%er 250 ~g ofMTg i.v. 
on days 0 and 7. Control groups received MTg alone or MTg incorporated in CFA. The data 
are represented as the mean of the indicated number of animals  _+ SE. 
14 days in mice given MTg in CFA. Although the antibodies detected in both 
groups were mercaptoethanol resistant, their concentration in mice immunized 
with MTg in CFA was approximately sixfold higher than in mice injected with 
MTg  and  LPS.  Histologically, the use of CFA resulted  in  mild  to moderate 
cellular infiltration in the thyroids of poor responder mice; the greatest pathol- 
ogy index found was 1.0 on day 21. No significant infiltration took place in the 
thyroids of mice treated with MTg and LPS. 
Since  MTg in  the  absence of LPS did  not  induce  any  detectable antibody 
formation, LPS administration apparently led to the abrogation of self-tolerance 
to MTg even in poor responder mice, although no thyroid lesions were induced. 
Still, compared to B10.D2 mice given CFA as adjuvant, the antibody levels were 
low. To determine if higher concentrations of antibody and significant thyroid- 
itis could be induced by increasing the LPS dosage, LPS was given to B10.D2 
mice on day 3 in addition to days 0 and 7. The animals were bled on days 14 and 
28 and thyroid sections obtained. Control mice were given MTg or LPS alone, or 
MTg in CFA. As seen in Table I, this additional dose of LPS resulted in earlier 1254  THYROIDITIS  INDUCTION  IN  MICE  WITH  LPS  AS  ADJUVANT PATRICIO  S.  ESQUIVEL,  NOEL  R.  ROSE,  AND  YI-CHI  M.  KONG  1255 
formation and higher levels of antibody to MTg, a portion of which was mercap- 
toethanol sensitive. In contrast, only mercaptoethanol-resistant antibody was 
observed in mice immunized with MTg in CFA.  Despite the higher titers of 
antibody, little infiltration was present in the thyroid of mice given MTg and 
LPS  (X3). Mice given MTg in CFA had still higher titers but only minimal 
lesions were evident in their thyroids. To monitor specific stimulation by LPS, 
antibody to LPS was also determined in this experiment. Both LPS-treated (X3) 
groups with or without lVITg showed comparable antibody titers to LPS; all 
samples were mercaptoethanol sensitive.  It is interesting that three of four 
animals given LPS (X3) alone had minimal thyroid lesions (0.2, 0.5 and 0.5) on 
day 28. 
Requirement of T Cells in the Adjuvanticity of  LPS.  We have demonstrated 
thus far that genetically based differences in response to MTg between mouse 
strains are evident when LPS is used as adjuvant. This genetic control has 
previously been shown to depend upon T cells (3). As a B-cell mitogen in mice, 
LPS might be expected to stimulate MTg-reactive B cells directly to respond to 
MTg. To determine if LPS could lead to a bypass of T-cell requirement for MTg, 
nude mice and their heterozygous  littermates were divided into groups of five to 
eight mice each and immunized with MTg in CFA or with soluble lVITg and LPS 
on days 0 and 7. On day 42, their sera and thyroids were examined for evidence 
of response to MTg.  The findings presented in Table II  show that LPS was 
ineffective as  an  adjuvant in  the  absence  of T  cells;  neither antibody nor 
infiltration in the thyroid was observed. In comparable heterozygous animals, 
mercaptoethanol-resistant antibodies were detected. The titers of antibody to 
MTg in the LPS-treated heterozygous mice were low and infiltrations of the 
thyroid minimal compared to higher titers and moderate infiltrations in similar 
animals  given  MTg  in  CFA.  The  results  in  these  mice  accord with  those 
observed in B10.D2 mice and are not surprising since both BALB/c and B10.D2 
strains share the same tt-2  d (poor responder) haplotype. 
To increase the probability of  detecting an adjuvant effect of LPS on B cells, T- 
cell-deficient good responder mice were prepared. B10.BR mice were thymecto- 
mized, irradiated, and reconstituted with syngeneic bone marrow cells (treated 
with anti4~ serum and complement) alone or together with thymus cells. They 
were then immunized on days 0 and 7 as before and killed on day 21. In addition 
to removing the blood and thyroid, tissues of  the mediastinum were obtained for 
histologic examination. The few animals with thymus remnants were elimi- 
nated from consideration. The results of one typical experiment are presented in 
Table III. It can be seen that mice that had recieved beth bone marrow and 
thymus cells and LPS or CFA as adjuvant exhibited antibody to MTg in high 
titers; marked infiltration with pathology indices of 1-3 was observed in 10 of 11 
animals.  Little difference in the degree of cellular infiltration was observed 
between the two groups. In contrast, mice that had received bone marrow cells 
only showed neither detectable antibody nor significant thyroid infiltration. 
Fro.  2.  Cellular infiltration in the thyroid of good responder  (B10.BR)  mice at 49 days 
after immunization with MTg using as adjuvant (a) LPS or (b) CFA. In both sections, the 
low magnification (x 40) shows a grade 3 infiltration involving  a large portion of the gland. 
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FIG. 4.  Effect  of LPS an the antibody response to MTg and thyroid pathology in poor 
responder (BI0.D2) mice. See legend  of  Fig. 1 for  immunization protocol. 
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Thus, in both good and poor responder mice, the abrogation of self-tolerance to 
MTg by LPS apparently requires the presence of T cells. 
Discussion 
These investigations reaffirm previous observations that mice fail to respond 
to soluble MTg, showing that the antigen was not significantly altered during 
extraction and preparation.  However,  LPS and CFA can  abrogate this self- 
tolerance. Several explanations have been advanced in the past for the ability of 
CFA to overcome the natural tolerance of mice to MTg. One is that macrophages 
and other granulomatous cells,  attracted by the acid-fast organisms and the 
water-in-oil emulsion, partially digest MTg and render it antigenic, as proteo- 
lytic enzymes can do in vitro (26). The acid-fast component, combined with a 
depot injection, may favor cell-mediated rather than humoral immunity. Also, 
the  emulsifying process by  itself may alter  MTg.  Such explanations cannot 
account for the adjuvant action of LPS. Although many other agents, including 
incomplete Freund's adjuvant (IFA) (27), aluminum salts (27), silica (27), alhy- 
drogel (28), and even latex particles (N. R. Rose and C. J. van Oss, unpublished 
observations), can act with homologous thyroglobulin (Tg)  in producing anti- 
FIG.  3.  Cellular infiltration in the thyroid of good responder (B10.BR) mice at 49 days 
after  immunization with  MTg  using  as  adjuvant  (a)  LPS  or  (b)  CFA.  In  this higher 
magnification (× 400) of Fig. 2, an abundance of infiltrating lymphocytes and macrophages 
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TABLE  I 
Effect of  Increasing the Dosage of  LPS on Immune Response to MTg in Poor Responder 
BIO.D2  Mice 
Immunization*  Day 
Mean log2 anti-MTg titer$  ±  SE 
Mean log2  Mean pathol- 
anti-LPS titer  ogy index$ 
-  Mercaptoeth-  +  Mercaptoeth-  ~- SE  --- SE 
anol  anol 
MTg +  LPS  (X3)  14  9.7  _  0.4  7.0  ±  1.5  0.7  ±  0.3  0.1  _+ 0.0 
28  7.2  _  1.2  3.5  _+  2.2  2.2  ±  0.6  0.3  4- 0.2 
MTg +  LPS (X2)  21  <1.0  0.1  ±  0.0 
42  5.9  +__ 1.5  0.0 
MTg in CFA  14  13.8  _  1.8  13.8  _  1.8  0.5  _+ 0.1 
28  15.5  ___ 0.5  15.5  _  0.5  0.5  ±  0.2 
MTg  14  <1.0  0.0 
28  <1.0  0.0 
LPS (X3)  14  <1.0  2.0  ___ 0.9  0.0 
28  <1.0  2.0  +__ 1.1  0.4  _  0.1 
* 250/zg of Tg was given on days 0 and 7 either subcutaneously in CFA or i.v. in a soluble form; 20 
/zg of LPS was injected i.v. on days 0, 3, and 7  (X3) or on days 0 and 7  (X2). 
$ Mean of four to eight mice per group; the lowest dilution tested in hemagglutination was 1:2. 
bodies to Tg in various species, only LPS adjuvant and CFA have been shown 
to induce concomitant thyroid lesions in mice. 
Since soluble MTg, injected in conjunction with LPS, induced an autoimmune 
response,  these  experiments further demonstrate that  self-tolerance can  be 
terminated by native Tg of the same species. It does not require postulating 
the involvement of cross-reactive T cells which can be stimulated by heterologous 
(4), haptenized (29), or emulsified (1-3)  Tg. We are thus able to implicate the 
participation of MTg-reactive T as well as B cells. 
The effectiveness of LPS as adjuvant for MTg is dependent upon the H-2 
haplotype of the animal, as shown by the use of congenic strains. In B10.BR (H- 
2 k) mice, the high levels of antibody to MTg and the extensive mononuclear cell 
infiltration in the thyroid of the LPS-treated group were comparable in quantity 
and quality to those observed in mice immunized with MTg in CFA (Figs. 1-3). 
In B10.D2  (H-2 d)  mice, LPS promoted the development of antibody to  MTg 
without concomitant cellular infiltration in the thyroid (Fig. 4).  This genetic 
restriction according to the H-2 haplotype follows the pattern for good and poor 
responder strains classified previously using MTg in CFA (2) and indicates that 
the  putative Ir-Tg  gene  codes  for  the  responsiveness to  MTg  rather  than 
susceptibility to CFA. 
In mice, response to MTg is T-cell dependent. By adoptive transfer studies, 
Vladutiu and Rose (3) showed that the H-2-1inked genetic regulation of respon- 
siveness to MTg, with subsequent thyroiditis, was dependent upon T cells. The 
genetic involvement of B cells, if present at all, played a minor role. Since these 
T-cell-based genetic differences in responsiveness to MTg are clearly evident 
h  LPS, it appears most likely that LPS promotes the development of thyroid- PATRICIO  S.  ESQUIVEL,  NOEL  R.  ROSE,  AND  YI-CHI  M.  KONG  1259 
TABLE  II 
T-Cell Requirement for the Adjuvant Action of  LPS on Immune Response to MTg in Poor 
Responder  (BALB/c) Nude Mice 
Pathology index$ 
Immuniza-  Mean log2 he- 
Genotype  tion*  magglutinin ti-  No. mice showing 
ter$ _  SE  Mean _+  SE 
-<0.5  1  2  3  4 
nu/nu  MTg +  LPS  <1.0  0.0  6 
MTg in CFA  <1.0  0.0  8 
+/nu  MTg +  LPS  8.5 _+ 2.6  0.1  -+ 0.1  5  .... 
MTgin CFA  13.1  _+  0.7  1.5  _+  0.4  1  4  1  -  1 
* 250 ~g of MTg was given on days 0 and 7 either subcutaneously in CFA or i.v. in a soluble form 
followed by 50 ~g of LPS i.v. 3 h  later. 
$ Obtained on day 42; the lowest dilution tested in hemagglutination was 1:2. 
itis in good responder mice by utilizing T cells, rather than by circumventing  the 
need for T cells (7,  8) and directly stimulating MTg-binding B cells (4). If we 
postulate that LPS activates MTg-reactive B cells, either directly as has been 
reported  for  foreign protein  and  haptenized  antigens  (30-33)  or  by  way  of 
macrophages (6), we would also have to suppose a  genetic regulation of the 
response to MTg in the B cells. 
Our data in thymectomized  and irradiated good responder mice showed that T 
cells were required for beth the production of antibody to MTg and thyroiditis 
(Table HI); no difference was observed between mice treated.with CFA or LPS as 
adjuvant in this regard. The requirement of T cells for LPS adjuvanticity was 
also found in poor responder mice where antibody, but little or no disease, was 
induced. Thus, athymic BALB/c (H-2  ~) mice failed to produce antibody to MTg, 
whereas their heterozygous littermates produced mercaptoethanol-resistant an- 
tibody when LPS was given as adjuvant (Table II). That T cells are required in 
demonstrating the adjuvant effect of LPS to several T-cell-dependent foreign 
antigens  (12, 13,  34) and homologous antigen  (35) has also been reported by 
other workers. 
In poor responder mice the antibody titers to MTg are generally lower than 
those in good responder mice. The difference in antibody production to MTg 
cannot be attributed to low responsiveness to LPS in poor responder mice, since 
LPS is mitogenic for spleen cells of beth B10.BR and B10.D2 mice (20). Further- 
more, when we compared the antibody titer to LPS in both strains, no signifi- 
cant difference could be found. 
To  see  if the  titer  of antibody was  the  main  determining factor  for  the 
development of thyroid lesions, poor responder mice were given an additional 
dose of LPS in an effort to increase their antibody levels to MTg.  Although 
antibody appeared earlier and reached higher titers, there was no evidence of 
greater thyroid infiltration (Table I). In addition, poor responder mice with very 
high titers of antibody (e.g. Table I, day 28 in the MTg-in-CFA group) showed 
only minimal infiltration, indicating that the levels of circulating antibody per 
se do not determine the establishment of thyroid lesions. Thus, MTg-reactive B 
cells in poor responder mice can be made to respond vigorously without bringing 1260  THYROIDITIS  INDUCTION  IN  MICE  WITH  LPS  AS  ADJUVANT 
TABLE  III 
T-Cell Requirement for the Adjuvant Action of LPS on Immune Response to MTg in 
Good Responder BIO.BR Mice 
Cells  trans-  Immunizations  ferred* 
Log2 hemagglutinin titer 
Mean ±  SE  No. positive§/  Mean ±  SE 
total 
Pathology  index 
No. mice showing 
-<0.5  1  2  3 
Bone marrow  MTg  <1.0  0/3  0.0  3 
MTg +  LPS  <1.0  0/5  0.0  5 
MTg in CFA  <1.0  0/5  0.2 -+ 0.1  5 
None  <1.0  0/4  0.0  - 
Bone  marrow  +  MTg  <1.0  0/3  0.2 ±  0.2  3 
thymus  MTg +  LPS  9.8 ±  2.2  5/6  1.1 ±  0.2  1 
MTg in CFA  14.3 ±  0.6  5/5  1.8  ±  0.4  - 
4  1  - 
2  2  1 
* Mice were thymectomized at 7 wk, exposed to 950 R at 11 wk, and reconstituted within 8 h. 
* 250/zg of MTg was given on days 0 and 7 either subcutaneously in CFA or i.v. in a soluble form; 20 pg of LPS was injected i.v. 3 h 
later. The animals were immunized 4 wk after reconstitution and killed 3 wk later. 
§ A log2 titer of 1 or above was considered positive; the antibodies were mercaptoethanol resistant. 
about the infiltration of effector cells in the thyroid. Further evidence that 
antibody level by itself does not determine the presence or absence of thyroid 
lesions  can  be  inferred from  an  experiment in  which  CFA  and  IFA  were 
compared directly as adjuvants in good responder (B10.BR) mice (P. S. Esquivel, 
unpublished  observations).  Antibody levels  were  equivalent but  only  mice 
given  MTg  in  CFA  had  lesions.  The  antibodies  were  indistinguishable by 
passive hemagglutination and mercaptoethanol reduction. 
Therefore, it  is  not a  question merely of reaching a  certain threshold of 
antibody to induce lesions. It may be that CFA, IFA, and LPS, as adjuvants, 
induce different antibody classes or subclasses. The antibodies may differ in 
affinity, or in ability to activate the complement system or to cooperate with a 
population of "killer" cells (36). Another possibility to explain the low incidence 
of thyroiditis even in the presence of high antibody levels is selective suppressor 
cell function.  Such  suppressors  must  interfere with  development of lesions 
without necessarily impeding antibody synthesis. But further study is required 
to examine these possibilities. 
Although there is increasing evidence that LPS acts on T cells as well as B 
cells, the mechanism of its adjuvant action on T cells is unknown. There are at 
least two possibilities.  One is that it stimulates T cells directly or via macro- 
phages to release nonspecific helper factors that activate MTg-reactive B cells. 
The other possibility for LPS action is that it activates (directly or indirectly) 
specific  MTg-reactive T  cells in the presence of MTg.  This hypothesis better 
explains the H-2-1inked differences  between good and poor responder strains. 
The absence of naturally occurring self-reactive T cells (4) has been suggested 
to explain self-tolerance (4, 5). More recently, T cells reactive with encephalito- 
genic protein (37) and membrane antigens (38) have been demonstrated. These 
autoreactive T cells may be held in check by suppressor cells or their soluble 
products (39), or by low levels of circulating antigen as has been postulated for 
Tg  (5,  40). Our finding that T  cells are the direct or indirect target of LPS 
adjuvant effect implies that T cells reactive to unaltered MTg are present in the 
mouse. More direct evidence supporting this view is provided by recent studies PATRICIO  S.  ESQUIVEL,  NOEL  R.  ROSE,  AND  YI-CHI  M.  KONG  1261 
showing that MTg is antigenic in good responder mice when given in conjunc- 
tion with polyadenylic-polyuridylic acid (41), an adjuvant with known effect on 
T cells (42). 
Summary 
The administration of soluble mouse thyroglobulin (MTg) in conjunction with 
bacterial lipopolysaccharide (LPS) led to the termination of natural tolerance to 
MTg in mice. The extent of autoimmunity correlated with responsiveness to MTg, 
previously shown by the injection of MTg in complete Freund's adjuvant (CFA) to 
be dependent upon the H-2  haplotype.  In good responder B10.BR (H-2  k) mice 
given MTg either with LPS or in CFA, high antibody levels to MTg and extensive 
mononuclear cell infiltration in the thyroid were observed. In contrast, congenic 
poor responder  B10.D2 (H-2 d) mice given MTg plus LPS showed low levels of 
antibody to MTg, compared to those receiving MTg in CFA, and insignificant 
cellular infiltration  of the thyroid. In no instance did autoimmunity develop in 
either good or poor responder strain  given MTg,  LPS, or CFA alone although 
LPS was antigenic in both of these congenic strains. 
Since the genetic difference in responsiveness to MTg is known to be T-cell 
based, the involvement of T cells in LPS-treated mice was suspected. This was 
further  ascertained  by the use of athymic poor responder  (BALB/c) mice and 
thymectomized, irradiated,  and bone marrow-reconstituted B10.BR mice. Anti- 
bodies to MTg were detected only in heterozygous  (nu/+)  mice  and  good re- 
sponder mice reconstituted with both thymus and bone marrow cells. In addi- 
tion, significant cellular infiltration in the thyroid occurred only in fully recon- 
stituted good responder mice. Thus,  the adjuvant effect of LPS on responsive- 
ness to MTg required T  cells.  Since unmodified MTg and LPS abrogated self- 
tolerance to MTg, the need for cross-reactive T  cells could be excluded. These 
observations suggest the presence of self-reactive T cells. 
Note Added in Proof.  After the submission of this manuscript, we received the Eur. 
J. Immunol. containing the article by D. B. Ness et al. (6:650, 19761). These workers also 
described the requirement of T cells for the adjuvant effect of LPS on the IgG response 
to (T, G)-A-L in both high and low responder mice. 
Received for publication 8 December 1976. 
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